AC Immune SA
NASDAQ:ACIU
Overview | Financials
Company Name | AC Immune SA |
Symbol | ACIU |
Currency | USD |
Price | 2.68 |
Market Cap | 267,143,472 |
Dividend Yield | 0% |
52-week-range | 2.25 - 4.978 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Andrea Pfeifer Ph.D. |
Website | https://www.acimmune.com |
An error occurred while fetching data.
About AC Immune SA
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD